ProCAID

• Research type

  Research Study

• Full title

  An open label phase I/randomised, double-blind phase II study in metastatic castration resistant Prostate Cancer of AZD5363 in combination with Docetaxel and prednisolone chemotherapy (ProCAID)

• IRAS ID

  135504

• Contact name

  Simon Crabb

• Contact email

  S.J.Crabb@southampton.ac.uk

• Sponsor organisation

  University Hospitals Southampton NHS Foundation Trust

• Eudract number

  2013-002391-41

• ISRCTN Number

  n/a

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  13/LO/1691

• Date of REC Opinion

  30 Dec 2013

• REC opinion

  Further Information Favourable Opinion